Insertion/insertion genotype of α2B-adrenergic receptor gene polymorphism is associated with silent myocardial ischemia in patients with type 2 diabetes mellitus

Clinical Biochemistry

Volumn 43, Issue 15, 2010, Pages 1201-1204

  Chen, Qiu Jing ^a   Lu, Lin ^a   Jin, Cao ^a   Wang, Ling Jie ^a   Zhang, Rui Yan ^a   Zhang, Qi ^a   Hu, Jian ^a   Yang, Zhen Kun ^a   Shen, Wei Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

2 adrenergic receptor; Diabetes; Polymorphism; Silent myocardial ischemia

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SILENT MYOCARDIAL ISCHEMIA; ST SEGMENT DEPRESSION;

AGED; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MULTIVARIATE ANALYSIS; MUTAGENESIS, INSERTIONAL; MYOCARDIAL ISCHEMIA; RECEPTORS, ADRENERGIC, ALPHA-2; REGRESSION ANALYSIS;

EID: 77956750531     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.07.023     Document Type: Article

References (32)

1. Chiarielle M., Indolfi C. Silent myocardial ischemia in patients with diabetes mellitus. Circulation 1996, 93:2089-2091.
2. Cohn P.F., Fox K.M., Daly C. Silent myocardial ischemia. Circulation 2003, 108:1263-1277.
3. Osorio A., Ortega E., Ruiz-Requena E. Two models of homocysteine behavior in acute myocardial infarction. Clin Biochem 2008, 41:277-281.
4. Koistinen M.J. Prevalence of asymptomatic myocardial ischemia in diabetic patients. BMJ 1990, 301:92-95.
5. Langer A., Freeman M.R., Josse R.G., Steiner G., Armstrong P.W. Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 1991, 67:1073-1078.
6. Valensi P., Sachs R.N., Lormeau B., Taupin J.M., Ouzan J., Blasco A., et al. Silent myocardial ischemia and left ventricular hypertrophy in diabetic patients. Diab Metab 1997, 23:409-416.
7. Naka M., Hiramatsu K., Aizawa T., Momose A., Yoshizawa K., Shigematsu S., et al. Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J 1992, 123:46-53.
8. Torremocha F., Hadjadj S., Carrie F., Rosenberg T., Herpin D., Marechaud R. Prediction of major coronary events by coronary risk profile and silent myocardial ischemia: prospective follow-up study of primary prevention in 72 diabetic patients. Diab Metab 2001, 27:49-57.
9. Valensi P., Paries J., Brulport-Cerisier V., Torremocha F., Sachs R.N., Vanzetto G., et al. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients, influence of age in a French multicenter study. Diab Care 2005, 28:2722-2727.
10. Puel J., Valensi P., Vanzetto G., Lassmann-Vague V., Monin J.L., Moulin P., et al. Identification of myocardial ischemia in the diabetic patients, joint ALFEDIAM and SFC recommendations. Diab Metab 2004, 30:3S3-3S18.
11. American Diabetes Association Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diab Care 1998, 21:1551-1559.
12. Kharlip J., Naglieri R., Mitchell B.D., Ryan K., Donner T.W. Screening for silent coronary heart disease in type 2 diabetes, clinical application of American Diabetes Association guidelines. Diab Care 2006, 29:692-694.
13. Gutterman D.D. Silent myocardial ischemia. Circ J 2009, 73:785-797.
14. Pertovaara A. Noradrenergic pain modulation. Prog Neurobiol 2006, 80:53-83.
15. Omiya Y., Yuzurihara M., Suzuki Y., Kase Y., Kono T. Role of alpha2- adrenoceptors in enhancement of antinociceptive effect in diabetic mice. Eur J Pharmacol 2008, 592:62-66.
16. Romero-Sandoval E.A., McCall C., Eisenach J.C. α2-adrenoceptor stimulation transforms immune responses in neuritis and blocks neuritis-induced pain. J Neurosci 2005, 25:8988-8994.
17. Sud R., Spengler R.N., Nader N.D., Ignatowski T.A. Antinociception occurs with a reversal in alpha2-adrenoceptor regulation of TNF production by peripheral monocytes/macrophages from pro- to anti-inflammatory. Eur J Pharmacol 2008, 588:217-231.
18. Neri Serneri G.G., Boddi M., Arata L., Rostagno C., Dabizzi P., Coppo M., et al. Silent ischemia in unstable angina is related to an altered cardiac norepinephrine handling. Circulation 1993, 87:1928-1937.
19. Nyquist P.A., Wityk R., Yanek L.R., Vaidya D., Yousem D.M., Becker L.C., et al. Silent small-vessel cerebrovascular disease and silent myocardial ischemia in families with premature coronary disease. Neuroepidemiology 2009, 33:66-67.
20. Heinonen P., Koulu M., Pesonen U., Karvonen M.K., Rissanen A., Laakso M., et al. Identification of a three amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J Clin Endocrinol Metab 1999, 84:2429-2433.
21. Small K.M., Brown K.M., Forbes S.L., Liggett S.B. Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J Biol Chem 2001, 276:4917-4922.
22. Maestu J., Allik J., Merenakk L., Eensoo D., Parik J., Veidebaum T., et al. Associations between an alpha 2A adrenergic receptor gene polymorphism and adolescent personality. Am J Med Genet B 2008, 147B:418-423.
23. Park J.S., Zhang S.Y., Jo S.H., Seo J.B., Li L., Park K.W., et al. Common adrenergic receptor polymorphisms as novel risk factors for vasospastic angina. Am Heart J 2006, 151:864-869.
24. Cosson E., Attali J.R., Valensi P. Markers for silent myocardial ischemia in diabetes. Are they helpful?. Diab Metab 2005, 31:205-213.
25. Beller G.A. Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients: is it appropriate and cost-effective?. J Am Coll Cardiol 2007, 49:1918-1923.
26. Snapir A., Heinonen P., Tuomainen T.P., Alhopuro P., Karvonen M.K., Lakka T.A., et al. An insertion/deletion polymorphism in the α2B-adenergic receptor gene is a novel genetic risk factor for acute coronary events. J Am Coll Cardiol 2001, 37:1516-1522.
27. Snapir A., Mikkelsson J., Perola M., Penttila A., Scheinin M., Karhunen P.J. Variation in the alpha2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death. J Am Coll Cardiol 2003, 41:190-194.
28. Von Wowern F., Bengtsson K., Lindblad U., Rastam L., Melander O. Functional variant in the α2B adrenoceptor gene, a positional candidate on chromosome 2, associates with hypertension. Hypertension 2004, 43:592-597.
29. Leiphart J.W., Dills C.V., Levy R.M. Decreased spinal alpha2a- and alpha2c-adenergic receptor subtype mRNA in a rat model of neuropathic pain. Neurosci Lett 2003, 349:5-8.
30. Nazarian A., Christianson C.A., Hua X.Y., Yaksh T.L. Dexmedetomidine and ST-91 analgesia in the formalin model is mediated by alpha2A-adrenoceptors: a mechanism of action distinct from morphine. Br J Pharmacol 2008, 155:1117-1126.
31. Wesolowska A., Young S., Dukat M. MD-354 potentiates the antinociceptive effect of clonidine in the mouse tail-flick but not hot-plate assay. Eur J Pharmacol 2004, 495:129-136.
32. Kohli U., Muszkat M., Sofowora G.G., Harris P.A., Friedman E.A., Dupont W.D., et al. Effects of variation in the human alpha2A- and alpha2C-adrenoceptor genes on cognitive tasks and pain perception. Eur J Pain 2010, 14:154-159.